

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | endothelial cell chemotaxis (GO:0035767) | 5.86622799 |
| 2 | response to peptidoglycan (GO:0032494) | 4.68986405 |
| 3 | cell migration involved in sprouting angiogenesis (GO:0002042) | 4.21352152 |
| 4 | positive regulation of p38MAPK cascade (GO:1900745) | 3.93386436 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.90527211 |
| 6 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.81096059 |
| 7 | regulation of p38MAPK cascade (GO:1900744) | 3.76296545 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 3.73581746 |
| 9 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.67825172 |
| 10 | detection of molecule of bacterial origin (GO:0032490) | 3.61462430 |
| 11 | negative regulation of interleukin-12 production (GO:0032695) | 3.60884950 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 3.52550200 |
| 13 | tolerance induction (GO:0002507) | 3.49458461 |
| 14 | cellular extravasation (GO:0045123) | 3.47603321 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 3.39913960 |
| 16 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.33009206 |
| 17 | detection of other organism (GO:0098543) | 3.29339215 |
| 18 | response to muramyl dipeptide (GO:0032495) | 3.27968817 |
| 19 | interferon-gamma production (GO:0032609) | 3.27850707 |
| 20 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.27474372 |
| 21 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.25595516 |
| 22 | blood vessel endothelial cell migration (GO:0043534) | 3.25151462 |
| 23 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.24183978 |
| 24 | negative regulation of fatty acid transport (GO:2000192) | 3.20417186 |
| 25 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.15036410 |
| 26 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.12762622 |
| 27 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.11833795 |
| 28 | detection of external biotic stimulus (GO:0098581) | 3.07113563 |
| 29 | detection of bacterium (GO:0016045) | 2.98462633 |
| 30 | growth hormone receptor signaling pathway (GO:0060396) | 2.96271210 |
| 31 | lung lobe morphogenesis (GO:0060463) | 2.94995222 |
| 32 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.94363348 |
| 33 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.93751315 |
| 34 | skin morphogenesis (GO:0043589) | 2.91133939 |
| 35 | positive thymic T cell selection (GO:0045059) | 2.90079860 |
| 36 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.87696340 |
| 37 | detection of biotic stimulus (GO:0009595) | 2.87588563 |
| 38 | NIK/NF-kappaB signaling (GO:0038061) | 2.87353931 |
| 39 | positive regulation of heat generation (GO:0031652) | 2.82064951 |
| 40 | hemidesmosome assembly (GO:0031581) | 2.81523288 |
| 41 | regulation of fever generation (GO:0031620) | 2.81398227 |
| 42 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.79344824 |
| 43 | response to laminar fluid shear stress (GO:0034616) | 2.78150403 |
| 44 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.75544556 |
| 45 | T-helper cell differentiation (GO:0042093) | 2.75266280 |
| 46 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.75266280 |
| 47 | mannose metabolic process (GO:0006013) | 2.75192784 |
| 48 | macrophage activation (GO:0042116) | 2.74533294 |
| 49 | mesodermal cell differentiation (GO:0048333) | 2.72380830 |
| 50 | response to interleukin-15 (GO:0070672) | 2.71206086 |
| 51 | negative regulation of interleukin-8 production (GO:0032717) | 2.70585376 |
| 52 | regulation of T cell tolerance induction (GO:0002664) | 2.69622737 |
| 53 | cell adhesion mediated by integrin (GO:0033627) | 2.67695661 |
| 54 | cellular response to growth hormone stimulus (GO:0071378) | 2.66583341 |
| 55 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.66367222 |
| 56 | positive regulation of astrocyte differentiation (GO:0048711) | 2.65226199 |
| 57 | thymic T cell selection (GO:0045061) | 2.63940759 |
| 58 | regulation of vitamin metabolic process (GO:0030656) | 2.62515016 |
| 59 | T-helper 1 type immune response (GO:0042088) | 2.62342212 |
| 60 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.60762033 |
| 61 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.60157650 |
| 62 | granulocyte activation (GO:0036230) | 2.59816923 |
| 63 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.59002903 |
| 64 | protein heterotrimerization (GO:0070208) | 2.58914581 |
| 65 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.58328947 |
| 66 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.58230197 |
| 67 | pinocytosis (GO:0006907) | 2.57496597 |
| 68 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.54212880 |
| 69 | regulation of leukocyte degranulation (GO:0043300) | 2.52508306 |
| 70 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.51631762 |
| 71 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.50957447 |
| 72 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.49533914 |
| 73 | substrate-dependent cell migration (GO:0006929) | 2.47681104 |
| 74 | regulation of mast cell degranulation (GO:0043304) | 2.47019377 |
| 75 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.46976350 |
| 76 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.46941009 |
| 77 | neutrophil activation (GO:0042119) | 2.45226981 |
| 78 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.44632314 |
| 79 | positive regulation of type 2 immune response (GO:0002830) | 2.44034917 |
| 80 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.43514719 |
| 81 | germ cell migration (GO:0008354) | 2.42219174 |
| 82 | decidualization (GO:0046697) | 2.42064732 |
| 83 | response to host (GO:0075136) | 2.39067949 |
| 84 | response to host defenses (GO:0052200) | 2.39067949 |
| 85 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.39067949 |
| 86 | defense response to protozoan (GO:0042832) | 2.38707518 |
| 87 | regulation of type 2 immune response (GO:0002828) | 2.38219533 |
| 88 | response to protozoan (GO:0001562) | 2.37993977 |
| 89 | neutrophil mediated immunity (GO:0002446) | 2.37706414 |
| 90 | positive T cell selection (GO:0043368) | 2.37059645 |
| 91 | negative regulation of interleukin-6 production (GO:0032715) | 2.36674540 |
| 92 | positive regulation of macrophage differentiation (GO:0045651) | 2.35957063 |
| 93 | myeloid dendritic cell differentiation (GO:0043011) | 2.35376383 |
| 94 | T cell differentiation involved in immune response (GO:0002292) | 2.34652887 |
| 95 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.34652887 |
| 96 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.34652887 |
| 97 | cellular response to interleukin-15 (GO:0071350) | 2.34399551 |
| 98 | apoptotic cell clearance (GO:0043277) | 2.34160311 |
| 99 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.33794108 |
| 100 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.33084891 |
| 101 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.32594441 |
| 102 | regulation of chemokine biosynthetic process (GO:0045073) | 2.32591854 |
| 103 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.32401167 |
| 104 | response to fluid shear stress (GO:0034405) | 2.32360684 |
| 105 | leukocyte aggregation (GO:0070486) | 2.32220242 |
| 106 | myeloid cell activation involved in immune response (GO:0002275) | 2.32185609 |
| 107 | positive regulation of tolerance induction (GO:0002645) | 2.32101117 |
| 108 | T cell selection (GO:0045058) | 2.31693724 |
| 109 | response to type I interferon (GO:0034340) | 2.31540144 |
| 110 | cellular response to type I interferon (GO:0071357) | 2.31088678 |
| 111 | type I interferon signaling pathway (GO:0060337) | 2.31088678 |
| 112 | wound healing, spreading of epidermal cells (GO:0035313) | 2.31030012 |
| 113 | positive regulation of bone remodeling (GO:0046852) | 2.31029946 |
| 114 | positive regulation of bone resorption (GO:0045780) | 2.31029946 |
| 115 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.30939443 |
| 116 | cellular response to epinephrine stimulus (GO:0071872) | 2.30763184 |
| 117 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.30392103 |
| 118 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.30012529 |
| 119 | mRNA transcription (GO:0009299) | 2.29358915 |
| 120 | immunoglobulin mediated immune response (GO:0016064) | 2.29211033 |
| 121 | negative regulation of type 2 immune response (GO:0002829) | 2.27843663 |
| 122 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.27729932 |
| 123 | regulation of podosome assembly (GO:0071801) | 2.27650684 |
| 124 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.26743359 |
| 125 | response to host immune response (GO:0052572) | 2.26743359 |
| 126 | embryonic process involved in female pregnancy (GO:0060136) | 2.25419939 |
| 127 | angiogenesis involved in wound healing (GO:0060055) | 2.24913613 |
| 128 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.24392870 |
| 129 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.24379673 |
| 130 | regulation of heat generation (GO:0031650) | 2.23749091 |
| 131 | low-density lipoprotein particle clearance (GO:0034383) | 2.22779875 |
| 132 | endodermal cell differentiation (GO:0035987) | 2.22216953 |
| 133 | regulation of interleukin-6 production (GO:0032675) | 2.21993364 |
| 134 | positive regulation of osteoclast differentiation (GO:0045672) | 2.21892452 |
| 135 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.21677963 |
| 136 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.21648337 |
| 137 | negative regulation of T cell mediated immunity (GO:0002710) | 2.20790213 |
| 138 | regulation of macrophage cytokine production (GO:0010935) | 2.20195167 |
| 139 | establishment of endothelial barrier (GO:0061028) | 2.19931885 |
| 140 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.19655620 |
| 141 | face morphogenesis (GO:0060325) | 2.18761546 |
| 142 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.18414636 |
| 143 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.18108844 |
| 144 | mature B cell differentiation involved in immune response (GO:0002313) | 2.17889669 |
| 145 | protein localization to endosome (GO:0036010) | 2.17861314 |
| 146 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.17742664 |
| 147 | cellular response to lipopolysaccharide (GO:0071222) | 2.17642741 |
| 148 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.17323148 |
| 149 | cellular response to gonadotropin stimulus (GO:0071371) | 2.14890607 |
| 150 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 2.12762691 |
| 151 | negative regulation of cell killing (GO:0031342) | 2.12650635 |
| 152 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.12650635 |
| 153 | myeloid dendritic cell activation (GO:0001773) | 2.11416250 |
| 154 | negative thymic T cell selection (GO:0045060) | 2.11234145 |
| 155 | collagen fibril organization (GO:0030199) | 2.11209249 |
| 156 | chondrocyte proliferation (GO:0035988) | 2.11096950 |
| 157 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.10932304 |
| 158 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.10932304 |
| 159 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.10932304 |
| 160 | modulation by symbiont of host immune response (GO:0052553) | 2.10932304 |
| 161 | positive regulation by symbiont of host defense response (GO:0052509) | 2.10932304 |
| 162 | modulation by symbiont of host defense response (GO:0052031) | 2.10932304 |
| 163 | response to gonadotropin (GO:0034698) | 2.10899684 |
| 164 | cell-substrate junction assembly (GO:0007044) | 2.10718633 |
| 165 | entrainment of circadian clock by photoperiod (GO:0043153) | 2.06645744 |
| 166 | gland morphogenesis (GO:0022612) | 2.06132722 |
| 167 | leukocyte cell-cell adhesion (GO:0007159) | 2.05599407 |
| 168 | regulation of tolerance induction (GO:0002643) | 2.05322910 |
| 169 | germinal center formation (GO:0002467) | 2.05227030 |
| 170 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.05072626 |
| 171 | alpha-beta T cell differentiation (GO:0046632) | 2.04946472 |
| 172 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.04717760 |
| 173 | negative T cell selection (GO:0043383) | 2.04568312 |
| 174 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.04170008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.99658850 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.91410541 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.22700161 |
| 4 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.84027630 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.54685987 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.07139478 |
| 7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.80947052 |
| 8 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.61849276 |
| 9 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.45410055 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.40642320 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.30087328 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.29077284 |
| 13 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.15965901 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.15038098 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.12238058 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.11082514 |
| 17 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.11040154 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.08093302 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.06551304 |
| 20 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.01954978 |
| 21 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.87569152 |
| 22 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.87563376 |
| 23 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82995783 |
| 24 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.81737439 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.81334776 |
| 26 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.76351226 |
| 27 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.76171511 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.75794576 |
| 29 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.69233440 |
| 30 | CJUN_26792858_Chip-Seq_BT549_Human | 1.67182836 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.66056176 |
| 32 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.63626194 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60782638 |
| 34 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.60197068 |
| 35 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.60197068 |
| 36 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.60192640 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59010367 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.57284743 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.55593124 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51859200 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.51688140 |
| 42 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.51241685 |
| 43 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49690471 |
| 44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.46897934 |
| 45 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44590862 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.42533007 |
| 47 | MYB_26560356_Chip-Seq_TH2_Human | 1.42398782 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.42344860 |
| 49 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.41980487 |
| 50 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.41157703 |
| 51 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.39562423 |
| 52 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38080473 |
| 53 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.36082255 |
| 54 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35396185 |
| 55 | * MAF_26560356_Chip-Seq_TH1_Human | 1.32660220 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.31743248 |
| 57 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31319360 |
| 58 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29812539 |
| 59 | TP53_16413492_ChIP-PET_HCT116_Human | 1.28896228 |
| 60 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28365906 |
| 61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28153389 |
| 62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28109447 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25746749 |
| 64 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.25073333 |
| 65 | MYC_22102868_ChIP-Seq_BL_Human | 1.24703280 |
| 66 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23229190 |
| 67 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22727224 |
| 68 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21463924 |
| 69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20129580 |
| 70 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.19698544 |
| 71 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.19266413 |
| 72 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.19161722 |
| 73 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18330546 |
| 74 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.16995222 |
| 75 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.16813932 |
| 76 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.16746017 |
| 77 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.16361145 |
| 78 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.16324393 |
| 79 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.15799521 |
| 80 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.15504780 |
| 81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14515176 |
| 82 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11330279 |
| 83 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.10736514 |
| 84 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10557036 |
| 85 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10557036 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10193504 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09760795 |
| 88 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09306085 |
| 89 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07929380 |
| 90 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.06265704 |
| 91 | * MYB_26560356_Chip-Seq_TH1_Human | 1.06036368 |
| 92 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05502651 |
| 93 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.05342711 |
| 94 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.04472728 |
| 95 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.03145804 |
| 96 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02787125 |
| 97 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02761303 |
| 98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02597164 |
| 99 | UTX_26944678_Chip-Seq_JUKART_Human | 1.02010686 |
| 100 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.01353589 |
| 101 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.01332649 |
| 102 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99556515 |
| 103 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99230099 |
| 104 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99094253 |
| 105 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.98878508 |
| 106 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98859673 |
| 107 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97844143 |
| 108 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.96845953 |
| 109 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96431519 |
| 110 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96064018 |
| 111 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95636500 |
| 112 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95383476 |
| 113 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95139025 |
| 114 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94852903 |
| 115 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.94234233 |
| 116 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93922812 |
| 117 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93741415 |
| 118 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.93647126 |
| 119 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.92644187 |
| 120 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92557836 |
| 121 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92557836 |
| 122 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90900946 |
| 123 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.89739170 |
| 124 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89403839 |
| 125 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88849601 |
| 126 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.87231036 |
| 127 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.87034391 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.29359587 |
| 2 | MP0003300_gastrointestinal_ulcer | 3.06752291 |
| 3 | MP0005275_abnormal_skin_tensile | 2.97933382 |
| 4 | MP0003303_peritoneal_inflammation | 2.97908239 |
| 5 | MP0004510_myositis | 2.95843345 |
| 6 | MP0003724_increased_susceptibility_to | 2.87691877 |
| 7 | MP0008004_abnormal_stomach_pH | 2.40260224 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 2.38765757 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.34986744 |
| 10 | MP0003436_decreased_susceptibility_to | 2.33548470 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.27461972 |
| 12 | MP0005076_abnormal_cell_differentiation | 2.11385280 |
| 13 | MP0004947_skin_inflammation | 2.10959530 |
| 14 | MP0003566_abnormal_cell_adhesion | 2.08810824 |
| 15 | MP0009840_abnormal_foam_cell | 2.08621471 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.07978882 |
| 17 | MP0009278_abnormal_bone_marrow | 2.05007826 |
| 18 | MP0003279_aneurysm | 2.03732829 |
| 19 | MP0000685_abnormal_immune_system | 1.96940848 |
| 20 | MP0001790_abnormal_immune_system | 1.91520111 |
| 21 | MP0005387_immune_system_phenotype | 1.91520111 |
| 22 | MP0002060_abnormal_skin_morphology | 1.83857861 |
| 23 | MP0001533_abnormal_skeleton_physiology | 1.82754960 |
| 24 | MP0003763_abnormal_thymus_physiology | 1.81043852 |
| 25 | MP0002405_respiratory_system_inflammati | 1.79374322 |
| 26 | MP0002877_abnormal_melanocyte_morpholog | 1.79190098 |
| 27 | MP0001851_eye_inflammation | 1.78576307 |
| 28 | MP0001958_emphysema | 1.77928917 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.77668678 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.74785860 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.74037364 |
| 32 | MP0005503_abnormal_tendon_morphology | 1.73732239 |
| 33 | MP0005023_abnormal_wound_healing | 1.72857265 |
| 34 | MP0006054_spinal_hemorrhage | 1.72536863 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.70044603 |
| 36 | MP0005451_abnormal_body_composition | 1.68060582 |
| 37 | MP0002254_reproductive_system_inflammat | 1.65171607 |
| 38 | MP0003828_pulmonary_edema | 1.63216204 |
| 39 | MP0002933_joint_inflammation | 1.62638365 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.61232562 |
| 41 | MP0010368_abnormal_lymphatic_system | 1.59630267 |
| 42 | MP0003091_abnormal_cell_migration | 1.59292260 |
| 43 | MP0003453_abnormal_keratinocyte_physiol | 1.55727923 |
| 44 | MP0003448_altered_tumor_morphology | 1.54497855 |
| 45 | MP0001853_heart_inflammation | 1.54322686 |
| 46 | MP0003045_fibrosis | 1.51168752 |
| 47 | * MP0002998_abnormal_bone_remodeling | 1.49438234 |
| 48 | MP0005390_skeleton_phenotype | 1.47774581 |
| 49 | MP0001800_abnormal_humoral_immune | 1.44806083 |
| 50 | MP0001873_stomach_inflammation | 1.43107377 |
| 51 | MP0001879_abnormal_lymphatic_vessel | 1.43018610 |
| 52 | MP0002006_tumorigenesis | 1.41642237 |
| 53 | MP0008961_abnormal_basal_metabolism | 1.39471292 |
| 54 | * MP0002419_abnormal_innate_immunity | 1.38602690 |
| 55 | * MP0002452_abnormal_antigen_presenting | 1.37911606 |
| 56 | MP0009785_altered_susceptibility_to | 1.36994175 |
| 57 | MP0008260_abnormal_autophagy | 1.36893031 |
| 58 | MP0002723_abnormal_immune_serum | 1.36829169 |
| 59 | MP0010234_abnormal_vibrissa_follicle | 1.36654831 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.36652645 |
| 61 | MP0002009_preneoplasia | 1.36318517 |
| 62 | MP0002148_abnormal_hypersensitivity_rea | 1.32063068 |
| 63 | MP0009764_decreased_sensitivity_to | 1.31883170 |
| 64 | MP0004272_abnormal_basement_membrane | 1.31105982 |
| 65 | MP0001243_abnormal_dermal_layer | 1.29452629 |
| 66 | MP0004883_abnormal_blood_vessel | 1.28977727 |
| 67 | MP0003866_abnormal_defecation | 1.28323270 |
| 68 | MP0005508_abnormal_skeleton_morphology | 1.25723920 |
| 69 | * MP0002420_abnormal_adaptive_immunity | 1.21915108 |
| 70 | * MP0001819_abnormal_immune_cell | 1.21175217 |
| 71 | MP0002332_abnormal_exercise_endurance | 1.20875025 |
| 72 | MP0005409_darkened_coat_color | 1.20697878 |
| 73 | MP0000733_abnormal_muscle_development | 1.19325320 |
| 74 | MP0005464_abnormal_platelet_physiology | 1.16522216 |
| 75 | MP0005164_abnormal_response_to | 1.15784386 |
| 76 | MP0001216_abnormal_epidermal_layer | 1.15204672 |
| 77 | MP0000465_gastrointestinal_hemorrhage | 1.15141985 |
| 78 | MP0000604_amyloidosis | 1.14410167 |
| 79 | MP0005025_abnormal_response_to | 1.14328023 |
| 80 | MP0000767_abnormal_smooth_muscle | 1.13748880 |
| 81 | MP0005671_abnormal_response_to | 1.13590560 |
| 82 | MP0001845_abnormal_inflammatory_respons | 1.11235849 |
| 83 | MP0000343_altered_response_to | 1.11029225 |
| 84 | MP0001881_abnormal_mammary_gland | 1.10278118 |
| 85 | MP0001545_abnormal_hematopoietic_system | 1.10191526 |
| 86 | MP0005397_hematopoietic_system_phenotyp | 1.10191526 |
| 87 | MP0000858_altered_metastatic_potential | 1.09717934 |
| 88 | MP0008469_abnormal_protein_level | 1.08326006 |
| 89 | MP0005623_abnormal_meninges_morphology | 1.08238636 |
| 90 | MP0001835_abnormal_antigen_presentation | 1.08235762 |
| 91 | MP0001542_abnormal_bone_strength | 1.07052449 |
| 92 | MP0002796_impaired_skin_barrier | 1.06574303 |
| 93 | MP0000249_abnormal_blood_vessel | 1.04873854 |
| 94 | MP0009384_cardiac_valve_regurgitation | 1.02517733 |
| 95 | * MP0003795_abnormal_bone_structure | 0.98600418 |
| 96 | MP0003941_abnormal_skin_development | 0.97732519 |
| 97 | MP0003690_abnormal_glial_cell | 0.94802279 |
| 98 | MP0000627_abnormal_mammary_gland | 0.89306780 |
| 99 | MP0001191_abnormal_skin_condition | 0.88310069 |
| 100 | MP0002398_abnormal_bone_marrow | 0.86589880 |
| 101 | MP0001849_ear_inflammation | 0.86489739 |
| 102 | MP0003075_altered_response_to | 0.85914171 |
| 103 | MP0002295_abnormal_pulmonary_circulatio | 0.84663290 |
| 104 | MP0005166_decreased_susceptibility_to | 0.83930556 |
| 105 | * MP0000716_abnormal_immune_system | 0.83522353 |
| 106 | MP0000703_abnormal_thymus_morphology | 0.83379453 |
| 107 | MP0006082_CNS_inflammation | 0.81676163 |
| 108 | * MP0002896_abnormal_bone_mineralization | 0.81590212 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.80734317 |
| 110 | MP0005257_abnormal_intraocular_pressure | 0.80485327 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.79990908 |
| 112 | MP0005595_abnormal_vascular_smooth | 0.79615741 |
| 113 | MP0002277_abnormal_respiratory_mucosa | 0.78882408 |
| 114 | MP0004782_abnormal_surfactant_physiolog | 0.78108758 |
| 115 | MP0005165_increased_susceptibility_to | 0.76298388 |
| 116 | MP0002168_other_aberrant_phenotype | 0.72694360 |
| 117 | MP0002722_abnormal_immune_system | 0.72609098 |
| 118 | MP0009333_abnormal_splenocyte_physiolog | 0.72206867 |
| 119 | MP0009931_abnormal_skin_appearance | 0.71159829 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.70224356 |
| 121 | * MP0002429_abnormal_blood_cell | 0.69001616 |
| 122 | MP0003329_amyloid_beta_deposits | 0.68935539 |
| 123 | MP0005310_abnormal_salivary_gland | 0.68282741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased density of long bones (HP:0006392) | 4.57544113 |
| 2 | Persistence of primary teeth (HP:0006335) | 4.39847706 |
| 3 | Premature rupture of membranes (HP:0001788) | 4.31318438 |
| 4 | Orchitis (HP:0100796) | 3.99166293 |
| 5 | Protrusio acetabuli (HP:0003179) | 3.97239845 |
| 6 | Optic neuritis (HP:0100653) | 3.73676871 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 3.73676871 |
| 8 | Aortic dissection (HP:0002647) | 3.70243318 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.63916704 |
| 10 | Myositis (HP:0100614) | 3.61455505 |
| 11 | Aortic aneurysm (HP:0004942) | 3.61190959 |
| 12 | Atrophic scars (HP:0001075) | 3.41656894 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.39548298 |
| 14 | Cerebral aneurysm (HP:0004944) | 3.38837192 |
| 15 | Abnormality of glycolipid metabolism (HP:0010969) | 3.37006302 |
| 16 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.37006302 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.37006302 |
| 18 | Amyloidosis (HP:0011034) | 3.17931835 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 3.11837624 |
| 20 | Shallow orbits (HP:0000586) | 3.11683015 |
| 21 | Peritonitis (HP:0002586) | 3.10419202 |
| 22 | Recurrent abscess formation (HP:0002722) | 2.96275439 |
| 23 | Dysostosis multiplex (HP:0000943) | 2.94679261 |
| 24 | Dilatation of the ascending aorta (HP:0005111) | 2.92938771 |
| 25 | Osteolytic defects of the hand bones (HP:0009699) | 2.90295457 |
| 26 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.90295457 |
| 27 | Mitral valve prolapse (HP:0001634) | 2.89589996 |
| 28 | Stomatitis (HP:0010280) | 2.88082731 |
| 29 | Broad metatarsal (HP:0001783) | 2.87265728 |
| 30 | Vascular tortuosity (HP:0004948) | 2.81793127 |
| 31 | Arterial tortuosity (HP:0005116) | 2.74922695 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.74115417 |
| 33 | Keratoconjunctivitis sicca (HP:0001097) | 2.69738636 |
| 34 | Increased IgE level (HP:0003212) | 2.65961597 |
| 35 | Fragile skin (HP:0001030) | 2.63836448 |
| 36 | Increased cerebral lipofuscin (HP:0011813) | 2.62869061 |
| 37 | Systemic lupus erythematosus (HP:0002725) | 2.59727450 |
| 38 | Increased connective tissue (HP:0009025) | 2.52604351 |
| 39 | Myocardial infarction (HP:0001658) | 2.52035449 |
| 40 | Abnormality of the nasal septum (HP:0000419) | 2.46198729 |
| 41 | Loss of speech (HP:0002371) | 2.45003067 |
| 42 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.43955841 |
| 43 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.43955841 |
| 44 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.43955841 |
| 45 | Mucopolysacchariduria (HP:0008155) | 2.43403510 |
| 46 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.43403510 |
| 47 | Alopecia of scalp (HP:0002293) | 2.43335959 |
| 48 | Arterial thrombosis (HP:0004420) | 2.43314831 |
| 49 | Spondylolisthesis (HP:0003302) | 2.42337061 |
| 50 | Milia (HP:0001056) | 2.41845842 |
| 51 | Broad face (HP:0000283) | 2.40741142 |
| 52 | Keratoconjunctivitis (HP:0001096) | 2.40595301 |
| 53 | Pulmonary infiltrates (HP:0002113) | 2.33180790 |
| 54 | Ankle contracture (HP:0006466) | 2.29392227 |
| 55 | Thick nail (HP:0001805) | 2.28611667 |
| 56 | Genu recurvatum (HP:0002816) | 2.26439602 |
| 57 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.25095471 |
| 58 | Cervical subluxation (HP:0003308) | 2.24534171 |
| 59 | Spinal cord lesions (HP:0100561) | 2.23120258 |
| 60 | Syringomyelia (HP:0003396) | 2.23120258 |
| 61 | Asymmetric septal hypertrophy (HP:0001670) | 2.19416251 |
| 62 | Hematochezia (HP:0002573) | 2.17210419 |
| 63 | Distal lower limb amyotrophy (HP:0008944) | 2.14600145 |
| 64 | Aneurysm (HP:0002617) | 2.13738580 |
| 65 | Rectal prolapse (HP:0002035) | 2.13681731 |
| 66 | Right ventricular cardiomyopathy (HP:0011663) | 2.13094529 |
| 67 | Malnutrition (HP:0004395) | 2.10393304 |
| 68 | Thin bony cortex (HP:0002753) | 2.10090636 |
| 69 | Upper limb muscle weakness (HP:0003484) | 2.06451961 |
| 70 | Neurofibrillary tangles (HP:0002185) | 2.05765770 |
| 71 | Spontaneous hematomas (HP:0007420) | 2.04166405 |
| 72 | Short nail (HP:0001799) | 2.03384466 |
| 73 | Absent frontal sinuses (HP:0002688) | 2.02123448 |
| 74 | Recurrent skin infections (HP:0001581) | 2.00738451 |
| 75 | Vacuolated lymphocytes (HP:0001922) | 2.00470110 |
| 76 | Interstitial pulmonary disease (HP:0006530) | 2.00196236 |
| 77 | Abnormality of the pericardium (HP:0001697) | 1.99784146 |
| 78 | Premature loss of primary teeth (HP:0006323) | 1.99606619 |
| 79 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.98586896 |
| 80 | Wormian bones (HP:0002645) | 1.97593417 |
| 81 | Bladder diverticulum (HP:0000015) | 1.96715664 |
| 82 | Striae distensae (HP:0001065) | 1.95704100 |
| 83 | Vertebral compression fractures (HP:0002953) | 1.95378088 |
| 84 | Soft skin (HP:0000977) | 1.93474813 |
| 85 | Hemoptysis (HP:0002105) | 1.93330845 |
| 86 | Follicular hyperkeratosis (HP:0007502) | 1.92678732 |
| 87 | Disproportionate tall stature (HP:0001519) | 1.91993151 |
| 88 | Recurrent fungal infections (HP:0002841) | 1.91358208 |
| 89 | Spinal rigidity (HP:0003306) | 1.88537318 |
| 90 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.88016259 |
| 91 | Axonal loss (HP:0003447) | 1.85203490 |
| 92 | Gangrene (HP:0100758) | 1.85189640 |
| 93 | Abnormality of complement system (HP:0005339) | 1.84850790 |
| 94 | Episodic fever (HP:0001954) | 1.84099972 |
| 95 | Pustule (HP:0200039) | 1.83576555 |
| 96 | Mitral regurgitation (HP:0001653) | 1.80548905 |
| 97 | Lower limb amyotrophy (HP:0007210) | 1.79010838 |
| 98 | Polygenic inheritance (HP:0010982) | 1.78449620 |
| 99 | Urticaria (HP:0001025) | 1.77314304 |
| 100 | Increased serum ferritin (HP:0003281) | 1.75496605 |
| 101 | Camptodactyly of toe (HP:0001836) | 1.73213695 |
| 102 | Blue sclerae (HP:0000592) | 1.71953582 |
| 103 | Nuclear cataract (HP:0100018) | 1.71688467 |
| 104 | Vasculitis (HP:0002633) | 1.70991772 |
| 105 | Autoimmune thrombocytopenia (HP:0001973) | 1.70965702 |
| 106 | Hypergammaglobulinemia (HP:0010702) | 1.70559779 |
| 107 | Emphysema (HP:0002097) | 1.70100733 |
| 108 | Glomerulonephritis (HP:0000099) | 1.68547224 |
| 109 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.68368568 |
| 110 | Obstructive sleep apnea (HP:0002870) | 1.68117766 |
| 111 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.66316346 |
| 112 | Subacute progressive viral hepatitis (HP:0006572) | 1.66192875 |
| 113 | Gingivitis (HP:0000230) | 1.65669649 |
| 114 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.64871838 |
| 115 | Recurrent viral infections (HP:0004429) | 1.64605251 |
| 116 | Colitis (HP:0002583) | 1.64091788 |
| 117 | Cerebral inclusion bodies (HP:0100314) | 1.63526419 |
| 118 | Elbow flexion contracture (HP:0002987) | 1.62617990 |
| 119 | Distal lower limb muscle weakness (HP:0009053) | 1.62399990 |
| 120 | Dislocated radial head (HP:0003083) | 1.61689409 |
| 121 | Joint laxity (HP:0001388) | 1.61592324 |
| 122 | Prolonged bleeding time (HP:0003010) | 1.60742130 |
| 123 | Narrow palate (HP:0000189) | 1.60647570 |
| 124 | Abnormality of primary teeth (HP:0006481) | 1.60636937 |
| 125 | Mitral stenosis (HP:0001718) | 1.60404930 |
| 126 | Complement deficiency (HP:0004431) | 1.59783319 |
| 127 | Epistaxis (HP:0000421) | 1.59764637 |
| 128 | Gastrointestinal infarctions (HP:0005244) | 1.58637842 |
| 129 | Mediastinal lymphadenopathy (HP:0100721) | 1.58175337 |
| 130 | Tibial bowing (HP:0002982) | 1.57500901 |
| 131 | Pulmonary artery stenosis (HP:0004415) | 1.57233712 |
| 132 | Flat acetabular roof (HP:0003180) | 1.56984557 |
| 133 | Abnormality of the peritoneum (HP:0002585) | 1.56734541 |
| 134 | Cellulitis (HP:0100658) | 1.55757651 |
| 135 | Hyperextensible skin (HP:0000974) | 1.54393565 |
| 136 | Ulnar claw (HP:0001178) | 1.54254235 |
| 137 | Acrocyanosis (HP:0001063) | 1.53035706 |
| 138 | Increased CSF protein (HP:0002922) | 1.52923400 |
| 139 | Abnormal platelet volume (HP:0011876) | 1.51299825 |
| 140 | Femoral bowing (HP:0002980) | 1.51182208 |
| 141 | Increased mean platelet volume (HP:0011877) | 1.50917083 |
| 142 | Pulmonary embolism (HP:0002204) | 1.50891116 |
| 143 | Bruising susceptibility (HP:0000978) | 1.50844801 |
| 144 | Abnormality of the radial head (HP:0003995) | 1.50156787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.48076847 |
| 2 | EPHA3 | 3.16439951 |
| 3 | TXK | 3.07835200 |
| 4 | EPHB1 | 2.97054416 |
| 5 | MAP3K14 | 2.89496205 |
| 6 | MAP4K1 | 2.59916720 |
| 7 | TGFBR2 | 2.48661079 |
| 8 | RIPK1 | 2.36718697 |
| 9 | TAOK3 | 2.09563719 |
| 10 | BLK | 2.06773873 |
| 11 | RIPK4 | 2.02959559 |
| 12 | IRAK3 | 2.00655847 |
| 13 | ERN1 | 1.88030957 |
| 14 | TTN | 1.83819586 |
| 15 | FGFR4 | 1.83040631 |
| 16 | JAK1 | 1.80799980 |
| 17 | MAP3K3 | 1.75136241 |
| 18 | TBK1 | 1.74651702 |
| 19 | NLK | 1.72909054 |
| 20 | ITK | 1.72754066 |
| 21 | CHUK | 1.72632231 |
| 22 | TAOK2 | 1.71613482 |
| 23 | FGFR3 | 1.71442964 |
| 24 | DMPK | 1.69645627 |
| 25 | IKBKB | 1.67186642 |
| 26 | IRAK4 | 1.66650213 |
| 27 | JAK3 | 1.62778187 |
| 28 | STK10 | 1.61532943 |
| 29 | BMX | 1.51606977 |
| 30 | TRIB3 | 1.50682021 |
| 31 | IKBKE | 1.46906590 |
| 32 | MAP3K13 | 1.46171644 |
| 33 | CDK12 | 1.43520018 |
| 34 | EEF2K | 1.39393019 |
| 35 | CDC42BPA | 1.39283303 |
| 36 | PIM2 | 1.39133403 |
| 37 | PTK6 | 1.38360574 |
| 38 | MOS | 1.36068797 |
| 39 | MAP3K6 | 1.31833776 |
| 40 | FER | 1.31334817 |
| 41 | PIM1 | 1.29312517 |
| 42 | ZAP70 | 1.25263536 |
| 43 | RPS6KA4 | 1.24766355 |
| 44 | MAPK15 | 1.19388148 |
| 45 | ICK | 1.18732065 |
| 46 | TEC | 1.18176195 |
| 47 | TYK2 | 1.17063245 |
| 48 | HCK | 1.16920931 |
| 49 | PDGFRB | 1.16149748 |
| 50 | BMPR2 | 1.13243562 |
| 51 | MAP3K10 | 1.11931212 |
| 52 | TRPM7 | 1.11874809 |
| 53 | IRAK2 | 1.11099507 |
| 54 | GRK7 | 1.10650045 |
| 55 | LATS1 | 1.08151759 |
| 56 | MATK | 1.03719384 |
| 57 | MAP3K2 | 1.01337709 |
| 58 | MAP2K3 | 1.01018703 |
| 59 | PDGFRA | 1.00257220 |
| 60 | MST4 | 0.97855356 |
| 61 | FES | 0.97160588 |
| 62 | DDR2 | 0.97096873 |
| 63 | MARK2 | 0.96618195 |
| 64 | EPHB2 | 0.96422722 |
| 65 | FGR | 0.94494822 |
| 66 | GSK3A | 0.93750934 |
| 67 | PTK2 | 0.91522972 |
| 68 | LATS2 | 0.90098210 |
| 69 | CSK | 0.89868253 |
| 70 | CDK6 | 0.88035042 |
| 71 | STK24 | 0.87448026 |
| 72 | TAOK1 | 0.87328986 |
| 73 | MAPK12 | 0.86131505 |
| 74 | TSSK6 | 0.85978048 |
| 75 | NUAK1 | 0.85931850 |
| 76 | LRRK2 | 0.85189352 |
| 77 | AKT3 | 0.84554830 |
| 78 | PRKD2 | 0.84004365 |
| 79 | FRK | 0.83149562 |
| 80 | TIE1 | 0.81155538 |
| 81 | PAK2 | 0.79142244 |
| 82 | PDPK1 | 0.78030732 |
| 83 | MAP3K1 | 0.77997597 |
| 84 | HIPK2 | 0.77921028 |
| 85 | GRK6 | 0.77020282 |
| 86 | JAK2 | 0.76902646 |
| 87 | MST1R | 0.76097019 |
| 88 | RPS6KA5 | 0.75726342 |
| 89 | KSR2 | 0.74724741 |
| 90 | BTK | 0.73819732 |
| 91 | RPS6KA2 | 0.73498947 |
| 92 | RPS6KA1 | 0.73115058 |
| 93 | EPHA2 | 0.72786588 |
| 94 | MAP3K7 | 0.72672744 |
| 95 | CSF1R | 0.72497010 |
| 96 | SIK1 | 0.70637245 |
| 97 | SMG1 | 0.70634488 |
| 98 | TGFBR1 | 0.69494222 |
| 99 | RPS6KC1 | 0.69408748 |
| 100 | RPS6KL1 | 0.69408748 |
| 101 | KDR | 0.68059757 |
| 102 | PRKCH | 0.67888111 |
| 103 | SGK3 | 0.67488675 |
| 104 | LCK | 0.67397086 |
| 105 | FGFR1 | 0.67031007 |
| 106 | IRAK1 | 0.64061043 |
| 107 | SIK3 | 0.64043286 |
| 108 | STK3 | 0.63849658 |
| 109 | PKN2 | 0.62220080 |
| 110 | MAPKAPK2 | 0.61508089 |
| 111 | MELK | 0.60969444 |
| 112 | CDK9 | 0.60404261 |
| 113 | PDK1 | 0.59988603 |
| 114 | PAK4 | 0.59567708 |
| 115 | SYK | 0.59136576 |
| 116 | PTK2B | 0.55885899 |
| 117 | MTOR | 0.54387832 |
| 118 | MAP3K5 | 0.53693421 |
| 119 | STK38 | 0.53281750 |
| 120 | RPS6KA6 | 0.53272677 |
| 121 | PIK3CG | 0.53010670 |
| 122 | PDK2 | 0.52623202 |
| 123 | RET | 0.51606735 |
| 124 | CAMK1D | 0.50893106 |
| 125 | INSR | 0.50549611 |
| 126 | MARK3 | 0.50222075 |
| 127 | CAMK1G | 0.50184208 |
| 128 | ABL2 | 0.49415644 |
| 129 | ALK | 0.49387203 |
| 130 | MAPK4 | 0.49366856 |
| 131 | LYN | 0.46411176 |
| 132 | MAP3K11 | 0.43799372 |
| 133 | ABL1 | 0.43459068 |
| 134 | MAP2K2 | 0.43388078 |
| 135 | PIK3CA | 0.42151384 |
| 136 | MAPK7 | 0.40765211 |
| 137 | IGF1R | 0.37698497 |
| 138 | FGFR2 | 0.37142946 |
| 139 | KIT | 0.36838620 |
| 140 | PRKG2 | 0.36825535 |
| 141 | STK11 | 0.36771194 |
| 142 | NEK9 | 0.36360376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.67532191 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.31126430 |
| 3 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.24328366 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.01001150 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.00596631 |
| 6 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.96133622 |
| 7 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.91884249 |
| 8 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.82573813 |
| 9 | Malaria_Homo sapiens_hsa05144 | 1.77407561 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.61962831 |
| 11 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.58822411 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.52660262 |
| 13 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49845946 |
| 14 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.44906155 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.42448301 |
| 16 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.41303438 |
| 17 | Focal adhesion_Homo sapiens_hsa04510 | 1.40241553 |
| 18 | Amoebiasis_Homo sapiens_hsa05146 | 1.38726671 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.38504598 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.36456706 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.34925991 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.34338192 |
| 23 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.31501568 |
| 24 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.31424921 |
| 25 | Adherens junction_Homo sapiens_hsa04520 | 1.30824281 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.30711322 |
| 27 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.28724771 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27445289 |
| 29 | Hepatitis B_Homo sapiens_hsa05161 | 1.26638823 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.24479080 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.23502554 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.23036518 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.22522478 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.18894201 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.15152354 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.15061036 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14831620 |
| 38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.13679544 |
| 39 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.12583992 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.11593403 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09889085 |
| 42 | Circadian rhythm_Homo sapiens_hsa04710 | 1.07801530 |
| 43 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.07128008 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.06954888 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.06776023 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.06197092 |
| 47 | Allograft rejection_Homo sapiens_hsa05330 | 1.05530892 |
| 48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.03831286 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 1.02757206 |
| 50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.00026486 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99956344 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 0.96934241 |
| 53 | HTLV-I infection_Homo sapiens_hsa05166 | 0.95838621 |
| 54 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.95770294 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.94243099 |
| 56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.93082798 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.93046743 |
| 58 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.92932501 |
| 59 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.92732019 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.92313685 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92073059 |
| 62 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.91266195 |
| 63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.90858880 |
| 64 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.89879706 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89775762 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.89754214 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88625961 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.88033710 |
| 69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.88007776 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.87949775 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.86184293 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.85840551 |
| 73 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83386807 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83243655 |
| 75 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.82971724 |
| 76 | Prostate cancer_Homo sapiens_hsa05215 | 0.80408892 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.80237466 |
| 78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78465786 |
| 79 | Colorectal cancer_Homo sapiens_hsa05210 | 0.78313375 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77004715 |
| 81 | Pathways in cancer_Homo sapiens_hsa05200 | 0.76845918 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.75951787 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75106827 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74436843 |
| 85 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.73903902 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73766822 |
| 87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.72582762 |
| 88 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72387828 |
| 89 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72324619 |
| 90 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.72113412 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70481075 |
| 92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70374041 |
| 93 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.70136683 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70040795 |
| 95 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68528217 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68012430 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65727741 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65441284 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65156392 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.63788380 |
| 101 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63145794 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61896829 |
| 103 | Asthma_Homo sapiens_hsa05310 | 0.61072881 |
| 104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60776305 |
| 105 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59773656 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58924488 |
| 107 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57911887 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57402955 |
| 109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57334188 |
| 110 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.57333065 |
| 111 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57003062 |
| 112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56902989 |
| 113 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.56575634 |
| 114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55265378 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53578438 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53342075 |
| 117 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52232900 |
| 118 | Glioma_Homo sapiens_hsa05214 | 0.52157843 |
| 119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51283846 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50724269 |

